FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

4668611000001108: Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21270101000001118 Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21270201000001113 Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule Is pack of Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule false Inferred relationship Existential restriction modifier
Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule Has active ingredient Ritonavir false Inferred relationship Existential restriction modifier
Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule Has active ingredient Lopinavir false Inferred relationship Existential restriction modifier
Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule Has VMP Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule Has specific active ingredient Ritonavir true Inferred relationship Existential restriction modifier
Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule Has specific active ingredient Lopinavir true Inferred relationship Existential restriction modifier
Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Kaletra capsules (Abbott Laboratories Ltd) 180 capsule 2 x 90 capsules Is a True Lopinavir 133.3mg / Ritonavir 33.3mg capsules 180 capsule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start